Alignment Healthcare, Inc. (ALHC) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $21.28. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ALHC = $658.70 (+2995.4% from the current price, the stock appears undervalued). Analyst consensus target is ALHC = $25 (+15.1% upside).
Valuation: ALHC trades at a trailing Price-to-Earnings (P/E) of -5780.2 (S&P 500 average ~25).
Financials: revenue is $3.9B, +40.5%/yr average growth. Net income is $724,000 (loss), growing at +38%/yr. Net profit margin is -0% (thin). Gross margin is 12.4% (-0.4 pp trend).
Balance sheet: total debt is $338M against $179M equity (Debt-to-Equity (D/E) ratio 1.89, leveraged). Current ratio is 1.74 (strong liquidity). Debt-to-assets is 31.7%. Total assets: $1.1B.
Analyst outlook: 14 / 16 analysts rate ALHC as buy (88%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 100/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 42/100 (Fail), Future 88/100 (Pass), Income 30/100 (Fail).
